[go: up one dir, main page]

NO960325L - Tryptaseinhibitor - Google Patents

Tryptaseinhibitor

Info

Publication number
NO960325L
NO960325L NO960325A NO960325A NO960325L NO 960325 L NO960325 L NO 960325L NO 960325 A NO960325 A NO 960325A NO 960325 A NO960325 A NO 960325A NO 960325 L NO960325 L NO 960325L
Authority
NO
Norway
Prior art keywords
vectors
new
inhlbltors
silk
fragments
Prior art date
Application number
NO960325A
Other languages
English (en)
Other versions
NO960325D0 (no
Inventor
Hans Fritz
Christian P Sommerhoff
Original Assignee
Ciba Geigy Ag
Ipc Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ipc Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of NO960325D0 publication Critical patent/NO960325D0/no
Publication of NO960325L publication Critical patent/NO960325L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nye Inhlbltorer av human tryptase, Isolering fra blodigler, nukleotldsekvenser kodende for nye inhlbltor molekyler eller fragmenter derav, vektorer Inneholdende de kodende sekvensene derav, vertsceller transformert med silke vektorer, rekombi- nant produksjon av Inhlbltorer, farmasøytiske sammensetninger Inneholdende nye Inhibltor molekyler og anvendelse l diagnostikk og terapi er beskrevet.
NO960325A 1993-07-26 1996-01-26 Tryptaseinhibitor NO960325L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93111930 1993-07-26
PCT/EP1994/002445 WO1995003333A2 (en) 1993-07-26 1994-07-25 Tryptase inhibitor

Publications (2)

Publication Number Publication Date
NO960325D0 NO960325D0 (no) 1996-01-26
NO960325L true NO960325L (no) 1996-01-26

Family

ID=8213112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960325A NO960325L (no) 1993-07-26 1996-01-26 Tryptaseinhibitor

Country Status (13)

Country Link
US (1) US5972698A (no)
EP (1) EP0714408B1 (no)
JP (1) JPH09500532A (no)
AT (1) ATE245660T1 (no)
AU (1) AU694444B2 (no)
CA (1) CA2164221A1 (no)
DE (1) DE69432975T2 (no)
FI (1) FI960333L (no)
NO (1) NO960325L (no)
NZ (1) NZ271635A (no)
SG (1) SG52658A1 (no)
TW (1) TW492975B (no)
WO (1) WO1995003333A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000500156A (ja) * 1995-11-13 2000-01-11 フールマン，ヘラルド ヒルから得られる抗ウイルス性単離物
WO1997022626A1 (en) * 1995-12-15 1997-06-26 Novartis Ag Ldti crystals
GB9916913D0 (en) * 1999-07-19 1999-09-22 Natural Enviromental Research Inhibitor proteins
CA2580881A1 (en) 2004-09-21 2006-03-30 Nascacell Technologies Ag Use of microproteins as tryptase inhibitors
CN108017693A (zh) * 2017-12-14 2018-05-11 中国科学院昆明动物研究所 一种抗凝肽syap-1及其突变体和包括抗凝肽和/或突变体的抑制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5187153A (en) * 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4912206A (en) * 1987-02-26 1990-03-27 The United States Of America As Represented By The Department Of Health And Human Services CDNA clone encoding brain amyloid of alzheimer's disease
JPH01110697A (ja) * 1987-07-03 1989-04-27 Taisho Pharmaceut Co Ltd 新規プロテアーゼ阻害物質
DE58907373D1 (de) * 1988-03-07 1994-05-11 Ciba Geigy Modifizierte Proteine.
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
KR920700287A (ko) * 1989-02-22 1992-02-19 사와무라 하루오 신규의 프로테아제 억제물질 및 그것의 제조방법
IL98405A0 (en) * 1990-06-11 1992-07-15 Fmc Corp Pharmaceutical compositions containing enzyme inhibiting agents

Also Published As

Publication number Publication date
AU694444B2 (en) 1998-07-23
FI960333A7 (fi) 1996-01-24
FI960333A0 (fi) 1996-01-24
AU7532494A (en) 1995-02-20
CA2164221A1 (en) 1995-02-02
EP0714408B1 (en) 2003-07-23
EP0714408A1 (en) 1996-06-05
US5972698A (en) 1999-10-26
NZ271635A (en) 1998-04-27
TW492975B (en) 2002-07-01
ATE245660T1 (de) 2003-08-15
NO960325D0 (no) 1996-01-26
JPH09500532A (ja) 1997-01-21
WO1995003333A3 (en) 1995-03-23
DE69432975T2 (de) 2004-05-06
FI960333L (fi) 1996-01-24
WO1995003333A2 (en) 1995-02-02
SG52658A1 (en) 1998-09-28
DE69432975D1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
HUP0101948A2 (hu) Il-2-szelektív agonisták és antagonisták
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
RU95115239A (ru) Аналог эритропоэтина
MY120693A (en) Human bikunin
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
NO882341D0 (no) Ekspresjon av humant proapolipoprotein a-i.
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
HUP0401124A2 (hu) VII koagulációs faktor származékok
TW200407425A (en) Human coagulation factor VII polypeptides
NZ271756A (en) Human macrophage inflammatory proteins and coding sequences, their production and use
ATE423788T1 (de) Neues tgf-beta-ahnliches cytokin
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
DE69322166D1 (de) Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon
TR199802537T2 (xx) Peptit t�revleri.
AR023482A1 (es) Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE60118359D1 (de) Humanische pellino-polypeptide
BR0312889A (pt) Polipeptìdeo t20 peguilado
NO960325L (no) Tryptaseinhibitor
ATE309382T1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
UA84831C2 (ru) Производные фактора коагуляции vii

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application